Back to Results

Cartesian Growth Corporation II (RENEF)

Cartesian Growth Corporation II is a common stock listing on OTC Markets. The company has no significant operating business and was formed to pursue a business combination, such as a merger, share exchange, asset acquisition, share purchase, reorganization, or a similar transaction, with one or more businesses or entities. Incorporated in 2021, it is headquartered in New York, New York.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
OTC-RENE.F
$13.79
8.5% Upside
Fair
—
—
—
Weak
—
—
—
0.0%
August 11, 2026
109.7x
-4.8x
—
112.2 M
121.3 M
7.6%
20.7%
0.0
—
-66.1%
Valuation • Fair Value

Cartesian Growth Corporation II (OTC-RENE.F) Fair Value by Valuation Model

Compare the primary fair value estimate for Cartesian Growth Corporation II (OTC-RENE.F) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$13.79

Estimated upside of 8.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$1.29

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$13.79

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Cartesian Growth Corporation II (OTC-RENE.F) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Cartesian Growth Corporation II (OTC-RENE.F)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

Not available

Data is currently unavailable.

Revenue Forecast

0 K

Forward revenue estimate.

EBITDA

0 K

Current operating profitability reference.

EBITDA Forecast

Not available

Data is currently unavailable.

How to read profitability and growth

This section helps investors review Cartesian Growth Corporation II (OTC-RENE.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cartesian Growth Corporation II (OTC-RENE.F)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

2

Weak quality score that deserves closer review.

Beneish M-Score

NM

Forensic accounting screen.

Altman Z-Score

0.0

Lower score that deserves closer risk review.

FCF / Net Income

-66.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cartesian Growth Corporation II (OTC-RENE.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cartesian Growth Corporation II (OTC-RENE.F)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 11, 2026

Days to Earnings

21

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Cartesian Growth Corporation II (OTC-RENE.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cartesian Growth Corporation II (OTC-RENE.F) Stock Forecast & Technical Outlook

Review Cartesian Growth Corporation II (OTC-RENE.F) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Not available

The 15-minute technical signal for Cartesian Growth Corporation II (OTC-RENE.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Not available

The 1-hour technical signal for Cartesian Growth Corporation II (OTC-RENE.F) is not currently available.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for Cartesian Growth Corporation II (OTC-RENE.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Cartesian Growth Corporation II (OTC-RENE.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Cartesian Growth Corporation II (OTC-RENE.F) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cartesian Growth Corporation II (OTC-RENE.F)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Cartesian Growth Corporation II (OTC-RENE.F) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Cartesian Growth Corporation II (OTC-RENE.F) Stock FAQ

Quick answers about Cartesian Growth Corporation II (OTC-RENE.F) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$13.79
Estimated upside 8.5%
Valuation Rating
Undervalued
Estimated upside of 8.5%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Weak
Current financial-health read

The current fair value estimate for Cartesian Growth Corporation II (OTC-RENE.F) is $13.79. This implies an estimated upside of 8.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 8.5% versus the current market price.

An analyst price target for Cartesian Growth Corporation II (OTC-RENE.F) is not currently available in the latest data file.

The current financial health read for Cartesian Growth Corporation II (OTC-RENE.F) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cartesian Growth Corporation II (OTC-RENE.F) is August 11, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Cartesian Growth Corporation II (OTC-RENE.F) is 109.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Cartesian Growth Corporation II is 112.2 M.

The current enterprise value listed for Cartesian Growth Corporation II is 121.3 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cartesian Growth Corporation II is OTC-RENE.F, and the stock is listed on OTC Markets.

Cartesian Growth Corporation II (OTC-RENE.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Cartesian Growth Corporation II is 7.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cartesian Growth Corporation II is 20.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Capital Markets Stocks on OTC Markets View more

Macquarie Group Ltd ADR (MQBKY) Macquarie Group Ltd ADR (MQBKY)
Hong Kong Exchange & Clearing (HKXCY) Hong Kong Exchange & Clearing (HKXCY)
CITIC Securities Co Ltd ADR (CIIHY) CITIC Securities Co Ltd ADR (CIIHY)
London Stock Exchange Ltd ADR (LSEGY) London Stock Exchange Ltd ADR (LSEGY)
Deutsche Boerse AG ADR (DBOEY) Deutsche Boerse AG ADR (DBOEY)
3i Group PLC ADR (TGOPY) 3i Group PLC ADR (TGOPY)
Partners Group (PGPHF) Partners Group (PGPHF)
Singapore Exchange Ltd ADR (SPXCY) Singapore Exchange Ltd ADR (SPXCY)
Scottish Mortgage Investment Trust PLC (STMZF) Scottish Mortgage Investment Trust PLC (STMZF)
Julius Baer Group Ltd (JBAXY) Julius Baer Group Ltd (JBAXY)
China Galaxy Securities Co Ltd ADR (CGXYY) China Galaxy Securities Co Ltd ADR (CGXYY)
Euronext NV ADR (ERNXY) Euronext NV ADR (ERNXY)
Daiwa Securities Group Inc ADR (DSEEY) Daiwa Securities Group Inc ADR (DSEEY)
B3 SA Brasil Bolsa Balcao ADR (BOLSY) B3 SA Brasil Bolsa Balcao ADR (BOLSY)
Japan Exchange Group Inc ADR (JPXGY) Japan Exchange Group Inc ADR (JPXGY)
IGM Financial Inc. (IGIFF) IGM Financial Inc. (IGIFF)
Schroders PLC (SHNWF) Schroders PLC (SHNWF)
Pershing Square Holdings Ltd (PSHZF) Pershing Square Holdings Ltd (PSHZF)
F&C Investment Trust PLC (FLIVF) F&C Investment Trust PLC (FLIVF)
ASX Limited ADR (ASXFY) ASX Limited ADR (ASXFY)
IG Group Holdings PLC ADR (IGGHY) IG Group Holdings PLC ADR (IGGHY)
St. James’s Place PLC (STJPF) St. James’s Place PLC (STJPF)
Investec Ltd ADR (ITCFY) Investec Ltd ADR (ITCFY)
ICG PLC (ICGUF) ICG PLC (ICGUF)